Ashurst is advising Acacia Pharma on its £15 million fundraising led by Fidelity Biosciences and Novo A/S. Existing shareholders Gilde Healthcare and Lundbeckfond Ventures are also participating.
The Ashurst team is led by corporate partner Anthony Clare, assisted by associate Kit Westropp.
International law firm Holman Fenwick Willan recently advised Niel Petroleum S.A. (Niel), a junior oil and gas company incorporated and headquartered in Luxembourg, in relation to the proposed issue to Niel by New World Oil and Gas Plc (NWOG), the oil and gas operating company currently focused on Belize and Denmark, of 2,184,897,959 shares (the Shares) and the provision of a loan.
Dentons’ Berlin office has advised Johanniter GmbH on the purchase of additional company shares in the Evangelische Kliniken Johanniter- und Waldkrankenhaus Bonn gGmbH (EKB), which operates two large hospitals in the Bonn area in Germany.
With this purchase, Johanniter GmbH will have increased its share of EKB from 76 to 100 percent. In 2012, Johanniter GmbH had already increased its stake in EKB from 51 to 76 percent.
Davis Polk advised Citigroup Global Markets Inc., Deutsche Bank Securities Inc. and Goldman, Sachs & Co. as dealer managers in connection with a cash tender offer by AngloGold Ashanti Holdings plc for any and all of the 3.5% guaranteed convertible bonds due 2014 issued by AngloGold Ashanti Holdings Finance plc.
Shearman & Sterling represented Morgan Stanley & Co. LLC, Barclays Capital Inc., J.P. Morgan Securities LLC, UBS Securities LLC, and Wells Fargo Securities, LLC as joint bookrunning managers and representatives of the several underwriters in connection with the $581.8 million (including overallotment option) public offering of common units representing limited partner interests of ONEOK Partners, L.P.
Paul Weiss client TransAlta Renewables Inc. closed its initial public offering of 20 million common shares at Cdn$10.00 per share. CIBC World Markets Inc. and RBC Dominion Securities Inc. co-led the syndicate of underwriters for the transaction.
TransAlta Renewables, a majority-owned subsidiary of Paul, Weiss client TransAlta Corporation, owns a portfolio of renewable power generation facilities and has one of the largest power generating capacities of any publicly traded renewable independent power producer in Canada.
Paul Hastings represented Fox Factory Holdings Inc., a designer, manufacturer and marketer of high performance suspension products, backed by Compass Group Diversified Holdings (NYSE:CODI) in connection with its initial public offering of common stock and listing on the Nasdaq Global Select Market.
Davis Polk advised J.P. Morgan Securities LLC, Merrill Lynch, Pierce, Fenner & Smith Incorporated and Leerink Swann LLC as joint book-running managers on an SEC-registered offering of 5,785,123 shares of common stock of The Medicines Company for an aggregate price to the public of approximately $175 million. The underwriters have a 30-day option to purchase up to an additional 867,768 shares. The Medicines Company’s common stock is listed on the NASDAQ Global Select Market under the trading symbol “MDCO.”
Davis Polk advised Morgan Stanley & Co. LLC and UBS Securities LLC as representatives of the underwriters in an SEC-registered public offering by Goodrich Petroleum Corporation of 4,800,000 depositary shares, each representing a 1/1000th interest in a share of its 9.75% Series D Cumulative Preferred Stock, par value $1.00, with a liquidation preference of $25,000 per share. The offering raised approximately $115.3 million in net proceeds.
Davis Polk advised Morgan Stanley & Co. LLC as the underwriter in an SEC-registered public offering of 6,895,873 shares of common stock, par value $0.0001 per share, of BioScrip, Inc., sold by affiliates of Kohlberg & Company, as the selling stockholders. The net proceeds from the offering totaled approximately $89.6 million.